APAC Glaucoma Treatment Market, Market Segmented, by Disease Indications (Closed Angle Glaucoma (Cag), Open Angle Glaucoma (Oag), Secondary Glaucoma, Congenital Glaucoma and Other), by Drug Class (Prostaglandin Analogs (Pgas), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors, And Others), by Surgery (Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery And Peripheral Iridectomy), and by End-User (Hospitals And Home Users)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138300
- Pages: 200
-
Format:
Report Overview
The APAC Glaucoma Treatment Market, market size stood at around USD $0.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eyes optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract
Market Drivers
The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc
1. APAC Glaucoma Treatment Market Overview
A. Market Size
2. APAC Glaucoma Treatment Market Growth Drivers and Restraints
A. Increasing at an impressive rate primarily driven by the growing number of geriatrics
B. Older population has higher risk of developing glaucoma although other age groups may be affected
C. Other highrisk groups include diabetics and those with a family history of glaucoma
D. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc
3. APAC Glaucoma Treatment Market Segmentation
A. By Disease Indication
I. Closed Angle Glaucoma (Cag)
II. Open Angle Glaucoma (Oag)
III. Secondary Glaucoma
IV. Congenital Glaucoma
V. Other
B. By Drug Class
I. Prostaglandin Analogs (Pgas)
II. Alpha Agonist
III. Beta Blockers
IV. Cholinergic Drugs
V. Carbonic Anhydrase Inhibitors
VI. Others
C. By Surgery
I. Laser Iridotomy
II. Laser Trabeculoplasty
III. Aqueous Shunt Surgery
IV. Peripheral Iridectomy
D. By End-User
I. Hospitals
II. Home Users
4. APAC Glaucoma Treatment Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Novartis AG, Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc, Company overview, Product & Services, Strategies & Financials
C. Allergan, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
